BRIACELL THERAPEUTICS CORP. Additional Paid in Capital, Common Stock
BRIACELL THERAPEUTICS CORP. (BCTX) had Additional Paid in Capital, Common Stock of $6.89 million as of 2023-04-30, per its 10-Q filed 2023-06-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2023-06-14
- 2023-04-30: Additional Paid in Capital, Common Stock $6.89M.
- 2023-01-31: Additional Paid in Capital, Common Stock $6.61M.
- 2022-10-31: Additional Paid in Capital, Common Stock $6.34M.
- 2022-07-31: Additional Paid in Capital, Common Stock $5.23M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2023-04-30 | $6.89M 10-Q · filed 2023-06-14 |
| 2023-01-31 | $6.61M 10-Q · filed 2023-03-16 |
| 2022-10-31 | $6.34M 10-Q · filed 2022-12-14 |
| 2022-07-31 | $5.23M 10-Q · filed 2023-06-14 |
| 2021-07-31 | $2.18M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |